Search results for "Irritable bowel syndrome"
In persons with constipation or IBS-C, kiwifruit vs. psyllium increased spontaneous bowel movements
Findings of the randomized trial bolster recommendations of diet manipulation and lifestyle modifications for chronic constipation syndromes, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2023/05/26/7.htm
26 May 2023
Mesalamine moderately useful in IBS, but confidence in evidence is low
The authors of a recent meta-analysis wrote that guidelines for irritable bowel syndrome (IBS) management should not recommend the drug until adequately powered studies are available.
https://gastroenterology.acponline.org/archives/2023/03/24/3.htm
24 Mar 2023
Response to linaclotide for IBS constipation can still appear after four weeks
An industry-funded analysis of four randomized trials of linaclotide for irritable bowel syndrome (IBS) with constipation found that improvement in abdominal and bowel symptoms occurred after four weeks of treatment in 1 in 6 and 1 in 10 patients, respectively.
https://gastroenterology.acponline.org/archives/2022/12/23/6.htm
23 Dec 2022
In drug-refractory IBS, group CBT with interoceptive exposure improved symptoms and quality of life at 13 wk
Given the results of this small, randomized trial, a head-to-head comparison of multidisciplinary care versus group cognitive behavioral therapy (CBT) delivered over the internet for patients with irritable bowel syndrome (IBS) is now warranted, an ACP Journal Club commentary noted.
https://gastroenterology.acponline.org/archives/2022/08/26/10.htm
26 Aug 2022
Recommendations for pharmacologic management of IBS with diarrhea, constipation
New guidelines suggest that there are several effective drugs available for irritable bowel syndrome (IBS), but a more detailed analysis indicates that the best treatments increase the rate of response by only 15% versus placebo, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2022/11/18/8.htm
18 Nov 2022
AGA issues guidance on drug treatment for patients with IBS
Two new clinical practice guidelines from the American Gastroenterological Association (AGA) provide recommendations on the use of medications to treat irritable bowel syndrome (IBS) with constipation and IBS with diarrhea.
https://gastroenterology.acponline.org/archives/2022/06/24/1.htm
24 Jun 2022
Antidepressants and psychological therapies reduce IBS symptoms, meta-analysis finds
Psychological therapies were effective for irritable bowel syndrome (IBS) when delivered in person, whereas therapy that was self-administered, internet-based, or provided with minimal contact did not yield significant benefit.
https://gastroenterology.acponline.org/archives/2018/09/28/2.htm
28 Sep 2018
Spotlight on long-term effects of FMT
Recent studies found evidence of long-term safety and efficacy of fecal microbiota transplantation (FMT) for irritable bowel syndrome and other GI diseases.
https://gastroenterology.acponline.org/archives/2022/06/24/5.htm
24 Jun 2022
AGA issues best practice advice on IBS and diet
Dietary advice is ideally prescribed to patients with irritable bowel syndrome (IBS) who have insight into their meal-related GI symptoms and are motivated to make changes, the American Gastroenterological Association (AGA) said.
https://gastroenterology.acponline.org/archives/2022/04/22/2.htm
22 Apr 2022
Spotlight on mental health and gastrointestinal symptoms
One recent study found a link between depression and diarrhea and constipation, while another found that cognitive behavioral therapy may be an effective treatment for patients with refractory irritable bowel syndrome.
https://gastroenterology.acponline.org/archives/2019/04/26/5.htm
26 Apr 2019